We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Astellas and Medivation Announce Initiation of Phase 2 Clinical Trial of MDV3100 in Hormone-Naive Prostate Cancer Patients

Product News   May 10, 2011

 
Astellas and Medivation Announce Initiation of Phase 2 Clinical Trial of MDV3100 in Hormone-Naive Prostate Cancer Patients
FURTHER INFORMATION
 
 
 

Related Product News

Visualizing Molecules With Augmented Reality

Product News

Sygnature have been developing the application of augmented reality for drug discovery, which has now reached the prototype stage.

READ MORE

New Training Module for Laboratory Information Management

Product News

CloudLIMS has announced the release of the training module for its Laboratory Information Management System (LIMS).

READ MORE

Efficient and Convenient Digital Melting Point Apparatus

Product News

The Stuart® SMP50 Automatic Digital Melting Point Apparatus can be used to analyze samples efficiently and conveniently.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE